Company: MFAN
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001055160-25-000018
Chunk: 134

Company: MFA FINANCIAL, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 134
---
 2024: Three Months EndedSeptember 30,Nine Months EndedSeptember 30,(In Thousands, Except Per Share Amounts)2025202420252024Basic Earnings/(Loss) per Share:Net income/(loss) to common stockholders$48,104 $48,183 $122,464 $113,342 Dividends declared on preferred stock(10,834)(8,219)(29,613)(24,656)Dividends, dividend equivalents and undistributed earnings allocated to participating securities(188)(94)(593)(367)Net income/(loss) attributable to common stockholders - basic$37,082 $39,870 $92,258 $88,319 Basic weighted average common shares outstanding103,683 103,647 103,721 103,423 Basic Earnings/(Loss) per Share$0.36 $0.38 $0.89 $0.85 Diluted Earnings/(Loss) per Share:Net income/(loss) to common stockholders - basic$37,082 $39,870 $92,258 $88,319 Dividends, dividend equivalents and undistributed earnings allocated to participating securities— — — — Interest expense on Convertible Senior Notes— — — — Net income/(loss) attributable to common stockholders - diluted$37,082 $39,870 $92,258 $88,319 Basic weighted average common shares outstanding103,683 103,647 103,721 103,423 Unvested and vested restricted stock units2,063 2,744 1,871 2,508 Effect of assumed conversion of Convertible Senior Notes to common shares— — — — Diluted weighted average common shares outstanding (1)105,746 106,391 105,592 105,931 Diluted Earnings/(Loss) per Share$0.35 $0.37 $0.87 $0.83 (1)At September 30, 2025 and 2024, the Company had approximately 707,000 and 235,000 equity instruments outstanding that were excluded from the calculation of diluted EPS for the three and nine months ended September 30, 2025 and 2024, as they were determined to be anti-dilutive.